|
Volumn 28, Issue 3, 1996, Pages 1176-1177
|
Unlimited-term passive immunoprophylaxis after liver transplantation in HBsAg-positive patients
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN A;
HEPA BIG;
HEPATITIS B ANTIBODY;
HEPATITIS B SURFACE ANTIGEN;
PREDNISONE;
UNCLASSIFIED DRUG;
VIRUS DNA;
ADULT;
ANTIBODY TITER;
ANTIGEN DETECTION;
CLINICAL ARTICLE;
CLINICAL FEATURE;
CONFERENCE PAPER;
DNA DETERMINATION;
DRUG MEGADOSE;
FEMALE;
GRAFT REJECTION;
HEPATITIS B;
HUMAN;
IMMUNOPROPHYLAXIS;
IMMUNOSUPPRESSIVE TREATMENT;
INTRAVENOUS DRUG ADMINISTRATION;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
LIVER FAILURE;
LIVER TRANSPLANTATION;
MALE;
PRIORITY JOURNAL;
ADULT;
FEMALE;
FOLLOW-UP STUDIES;
HEPATITIS B;
HEPATITIS B SURFACE ANTIGENS;
HEPATITIS B VIRUS;
HUMANS;
IMMUNIZATION, PASSIVE;
LIVER TRANSPLANTATION;
MALE;
MIDDLE AGED;
REOPERATION;
SURVIVAL RATE;
TIME FACTORS;
VIRUS REPLICATION;
|
EID: 0029885401
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (4)
|
References (0)
|